Haw Par

Update in progress

H02.SI (SES)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - General

Haw Par Corporation Limited and its subsidiaries manufacture, market, and trade healthcare products in Singapore, ASEAN and other regions. It produces and distributes topical analgesics under Tiger Balm and Kwan Loong, and invests in quoted securities. The group owns and leases investment properties, operates family and tourist leisure activities such as oceanariums, and engages in property development, office lettings, and management services. Founded in 1969, it is based in Singapore.

Company score

Sentiment: 0.27; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.03; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.31; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.14; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.13; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.20; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive